Quick Answer
Maze Therapeutics, Inc. reported Total Revenue of $167.50 million for the year ending 2024.
- This data is from Maze Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2024 to 2024 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2024: $165.00 million | Q3 2024: $2.50 million | Q2 2025: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: